Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > My Telesta Response.......typed verbatim part 2
View:
Post by txbioinv on Nov 20, 2015 2:08pm

My Telesta Response.......typed verbatim part 2

Dear ........., Thank you for your note and we appreciate your advocacy. Please know that on our side that we will continue to work very hard and diligently with the FDA over the next 3 months a they complete their review of our filing. While disappointing, the panels vote is not decisional and we are encouraged that all but one of the practicing urologists on the panel voted in favor of MCNA. Best Regards, Don
Comment by ragingbull1327 on Nov 20, 2015 2:10pm
Sounds legit.   More legit than the stock trading.   Why doesn't someone cry foul on that? 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities